Ignite Creation Date:
2024-05-06 @ 6:25 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05650918
Status:
COMPLETED
Last Update Posted:
2023-10-12
First Post:
2022-08-08
Brief Title:
MesoPherMitazalimab-combination Therapy in Metastatic Pancreatic Disease REACtiVe-2 Trial
Sponsor:
Organization:
Erasmus Medical Center